Drug Trial Radar · NCT05085561
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Mar 17, 2022
Primary completion
Jun 30, 2025
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- Recursion Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy and pharmacokinetics of REC-994 (200 mg and 400 mg) compared to placebo in participants with symptomatic cerebral cavernous malformation (CCM).
Conditions
- Cerebral Cavernous Malformation
Interventions
REC-994Drug
REC-994 200 mg tablets
PlaceboDrug
Placebo Tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Up to a maximum of 1201 days
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Xenoscience Inc
Phoenix, Arizona
UCLA
Los Angeles, California
Stanford University
Palo Alto, California
University of Florida
Gainesville, Florida
Lyerly Neurosurgery
Jacksonville, Florida
Cleveland Clinic Florida
Port Saint Lucie, Florida
Emory
Atlanta, Georgia
Valley Hospital
Ridgewood, New Jersey
Columbia University Medical Center
New York, New York
University of Rochester Medical Center
Rochester, New York
Thomas Jefferson University
Philadelphia, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania
The University of Texas Southwestern Medical Center
Dallas, Texas
University of Virginia
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.